Concepedia

Loredana Cleris

LC

Statistics

Publications

40

Citations

3K

H-Index

28

Active since

1988

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

University of Milan

Tumori Foundation

University of Milano-Bicocca

McGill University

Loredana Cleris is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1988–2022

40

Publications

40

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells

Valentina Zuco, Rosanna Supino, Sabina Carla Righetti et al. · Cancer Letters · 2002 · 521 citations

, , +9

In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

Philipp le Coutre, Luca Mologni, Loredana Cleris et al. · JNCI Journal of the National Cancer Institute · 1999 · 377 citations · Full text

<i>In vitro</i> and <i>In vivo</i> Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells

Miriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli et al. · Cancer Research · 2006 · 368 citations

, , +13

Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity.

Franca Formelli, Loredana Cleris · PubMed · 1993 · 134 citations

, , +15

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression

Rosanna Supino, Mariacristina Crosti, Andrea Warlters et al. · International Journal of Cancer · 1996 · 119 citations · Full text

1–5 of 40